{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:51:27Z","timestamp":1790261487600,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Education Malaysia under Long Term Research Grant Scheme"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Zika virus (ZIKV) infection is a serious public health concern. ZIKV infection has been associated with increased occurrences of microcephaly among newborns and incidences of Guillain-Barr\u00e9 syndrome among adults. No specific therapeutics or vaccines are currently available to treat and protect against ZIKV infection. Here, a plant-secreted phytoalexin, resveratrol (RES), was investigated for its ability to inhibit ZIKV replication\n                    <jats:italic>in vitro<\/jats:italic>\n                    . Several RES treatment regimens were used. The ZIKV titers of mock- and RES-treated infected cell cultures were determined using the focus-forming assay and the Zika mRNA copy number as determined using qRT-PCR. Our results suggested that RES treatment reduced ZIKV titers in a dose-dependent manner. A reduction of &gt;90% of virus titer and ZIKV mRNA copy number was achieved when infected cells were treated with 80\u2009\u00b5M of RES post-infection. Pre-incubation of the virus with 80\u2009\u00b5M RES showed &gt;30% reduction in ZIKV titers and ZIKV mRNA copy number, implying potential direct virucidal effects of RES against the virus. The RES treatment reduced &gt;70% virus titer in the anti-adsorption assay, suggesting the possibility that RES also interferes with ZIKV binding. However, there was no significant decrease in ZIKV titer when a short-period of RES treatment was applied to cells before ZIKV infection (pre-infection) and after the virus bound to the cells (virus internalization inhibition), implying that RES acts through its continuous presence in the cell cultures after virus infection. Overall, our results suggested that RES exhibited direct virucidal activity against ZIKV and possessed anti-ZIKV replication properties, highlighting the need for further exploration of RES as a potential antiviral molecule against ZIKV infection.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-50674-3","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T06:02:49Z","timestamp":1570168969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Resveratrol affects Zika virus replication in vitro"],"prefix":"10.1038","volume":"9","author":[{"given":"Azirah","family":"Mohd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhafiza","family":"Zainal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-9146","authenticated-orcid":false,"given":"Kim-Kee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazaly","family":"AbuBakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"50674_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2471\/BLT.16.171082","volume":"94","author":"MK Kindhauser","year":"2016","unstructured":"Kindhauser, M. K., Allen, T., Frank, V., Santhana, R. S. & Dye, C. Zika: the origin and spread of a mosquito-borne virus. Bull. World Health Organ. 94, 675\u2013686C, https:\/\/doi.org\/10.2471\/BLT.16.171082 (2016).","journal-title":"Bull. World Health Organ."},{"key":"50674_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2017.03.001","volume":"308","author":"BH Song","year":"2017","unstructured":"Song, B. H., Yun, S. I., Woolley, M. & Lee, Y. M. Zika virus: History, epidemiology, transmission, and clinical presentation. J. Neuroimmunol. 308, 50\u201364, https:\/\/doi.org\/10.1016\/j.jneuroim.2017.03.001 (2017).","journal-title":"J. Neuroimmunol."},{"key":"50674_CR3","doi-asserted-by":"publisher","first-page":"O595","DOI":"10.1111\/1469-0691.12707","volume":"20","author":"D Musso","year":"2014","unstructured":"Musso, D., Nilles, E. J. & Cao-Lormeau, V. M. Rapid spread of emerging Zika virus in the Pacific area. Clin. Microbiol. Infect. 20, O595\u2013596, https:\/\/doi.org\/10.1111\/1469-0691.12707 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"50674_CR4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3201\/eid2006.140138","volume":"20","author":"VM Cao-Lormeau","year":"2014","unstructured":"Cao-Lormeau, V. M. et al. Zika virus, French polynesia, South pacific, 2013. Emerg. Infect. Dis. 20, 1085\u20131086, https:\/\/doi.org\/10.3201\/eid2006.140138 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"50674_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S2055-6640(20)30330-7","volume":"3","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel, F. A., Viveros-Sandoval, M. E. & Reyes-Sandoval, A. Current trends in Zika vaccine development. J. Virus Erad. 3, 124\u2013127 (2017).","journal-title":"J. Virus Erad."},{"key":"50674_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3947\/ic.2017.49.2.91","volume":"49","author":"SK Lim","year":"2017","unstructured":"Lim, S. K., Lim, J. K. & Yoon, I. K. An Update on Zika Virus in. Asia. Infect. Chemother. 49, 91\u2013100, https:\/\/doi.org\/10.3947\/ic.2017.49.2.91 (2017).","journal-title":"Asia. Infect. Chemother."},{"key":"50674_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12250-016-3774-9","volume":"31","author":"S Shen","year":"2016","unstructured":"Shen, S. et al. Phylogenetic analysis revealed the central roles of two African countries in the evolution and worldwide spread of Zika virus. Virol. Sin. 31, 118\u2013130, https:\/\/doi.org\/10.1007\/s12250-016-3774-9 (2016).","journal-title":"Virol. Sin."},{"key":"50674_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1231-2","volume":"15","author":"CT Diagne","year":"2015","unstructured":"Diagne, C. T. et al. Potential of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit Zika virus. BMC Infect. Dis. 15, 492, https:\/\/doi.org\/10.1186\/s12879-015-1231-2 (2015).","journal-title":"BMC Infect. Dis."},{"key":"50674_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3201\/eid1705.101939","volume":"17","author":"BD Foy","year":"2011","unstructured":"Foy, B. D. et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880\u2013882, https:\/\/doi.org\/10.3201\/eid1705.101939 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"50674_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3201\/eid2102.141363","volume":"21","author":"D Musso","year":"2015","unstructured":"Musso, D. et al. Potential sexual transmission of Zika virus. Emerg. Infect. Dis. 21, 359\u2013361, https:\/\/doi.org\/10.3201\/eid2102.141363 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"50674_CR11","doi-asserted-by":"crossref","unstructured":"Besnard, M., Lastere, S., Teissier, A., Cao-Lormeau, V. & Musso, D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill. 19 (2014).","DOI":"10.2807\/1560-7917.ES2014.19.13.20751"},{"key":"50674_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tracli.2014.08.005","volume":"21","author":"D Bierlaire","year":"2014","unstructured":"Bierlaire, D., Beau, F., Lastere, S., Musso, D. & Broult, J. Virus ZIKA en Polyn\u00e9sie fran\u00e7aise: h\u00e9movigilance receveur. Transfusion Clinique et Biologique 21, 234 (2014).","journal-title":"Transfusion Clinique et Biologique"},{"key":"50674_CR13","doi-asserted-by":"publisher","first-page":"e1477","DOI":"10.1371\/journal.pntd.0001477","volume":"6","author":"AD Haddow","year":"2012","unstructured":"Haddow, A. D. et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis. 6, e1477, https:\/\/doi.org\/10.1371\/journal.pntd.0001477 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"50674_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.medmal.2014.04.008","volume":"44","author":"S Ioos","year":"2014","unstructured":"Ioos, S. et al. Current Zika virus epidemiology and recent epidemics. Med. Mal. Infect. 44, 302\u2013307, https:\/\/doi.org\/10.1016\/j.medmal.2014.04.008 (2014).","journal-title":"Med. Mal. Infect."},{"key":"50674_CR15","first-page":"3","volume":"3","author":"B Sharifi-Mood","year":"2016","unstructured":"Sharifi-Mood, B., Sharifi, R. & Barati, Z. Zika Virus Infection. Int. J. of Infect. 3, 3 (2016).","journal-title":"Int. J. of Infect."},{"key":"50674_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2522-6","volume":"17","author":"S Mattar","year":"2017","unstructured":"Mattar, S. et al. Case report: microcephaly associated with Zika virus infection, Colombia. BMC Infect. Dis. 17, 423, https:\/\/doi.org\/10.1186\/s12879-017-2522-6 (2017).","journal-title":"BMC Infect. Dis."},{"key":"50674_CR17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539, https:\/\/doi.org\/10.1016\/S0140-6736(16)00562-6 (2016).","journal-title":"Lancet"},{"key":"50674_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep42998","volume":"7","author":"N Zainal","year":"2017","unstructured":"Zainal, N. et al. Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection. Sci. Rep. 7, 42998, https:\/\/doi.org\/10.1038\/srep42998 (2017).","journal-title":"Sci. Rep."},{"key":"50674_CR19","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.3390\/molecules19068151","volume":"19","author":"RR Teixeira","year":"2014","unstructured":"Teixeira, R. R. et al. Natural products as source of potential dengue antivirals. Molecules 19, 8151\u20138176, https:\/\/doi.org\/10.3390\/molecules19068151 (2014).","journal-title":"Molecules"},{"key":"50674_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2017.09.006","volume":"147","author":"P Behrendt","year":"2017","unstructured":"Behrendt, P. et al. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. Antiviral Res. 147, 19\u201328, https:\/\/doi.org\/10.1016\/j.antiviral.2017.09.006 (2017).","journal-title":"Antiviral Res."},{"key":"50674_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.celrep.2017.03.071","volume":"19","author":"D Estoppey","year":"2017","unstructured":"Estoppey, D. et al. The natural product Cavinafungin selectively interferes with Zika and Dengue virus replication by inhibition of the host signal peptidase. Cell Rep. 19, 451\u2013460, https:\/\/doi.org\/10.1016\/j.celrep.2017.03.071 (2017).","journal-title":"Cell Rep."},{"key":"50674_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep05452","volume":"4","author":"E Moghaddam","year":"2014","unstructured":"Moghaddam, E. et al. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 4, 5452, https:\/\/doi.org\/10.1038\/srep05452 (2014).","journal-title":"Sci. Rep."},{"key":"50674_CR23","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/molecules17032437","volume":"17","author":"K Zandi","year":"2012","unstructured":"Zandi, K. et al. Flavone enhances dengue virus type-2 (NGC strain) infectivity and replication in vero cells. Molecules 17, 2437\u20132445, https:\/\/doi.org\/10.3390\/molecules17032437 (2012).","journal-title":"Molecules"},{"key":"50674_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","volume":"376","author":"KI Hidari","year":"2008","unstructured":"Hidari, K. I. et al. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem. Biophys. Res. Commun. 376, 91\u201395, https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.100 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"50674_CR25","doi-asserted-by":"publisher","first-page":"062000","DOI":"10.4172\/jaa.1000009","volume":"1","author":"J Yin Low","year":"2009","unstructured":"Yin Low, J., Chen, K., Wu, K. & Mah-LeeNm, H. Antiviral activity of emetine dihydrochloride against dengue virus infection. J. Antivir. Antiretrovir. 1, 062000 (2009).","journal-title":"J. Antivir. Antiretrovir."},{"key":"50674_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.phytochem.2012.07.023","volume":"84","author":"PM Allard","year":"2012","unstructured":"Allard, P. M. et al. Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri. Phytochemistry 84, 160\u2013168, https:\/\/doi.org\/10.1016\/j.phytochem.2012.07.023 (2012).","journal-title":"Phytochemistry"},{"key":"50674_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1021\/np300059n","volume":"75","author":"M Bourjot","year":"2012","unstructured":"Bourjot, M. et al. Flacourtosides A-F, Phenolic Glycosides Isolated from Flacourtia ramontchi. J. Nat. Prod. 75, 752\u2013758, https:\/\/doi.org\/10.1021\/np300059n (2012).","journal-title":"J. Nat. Prod."},{"key":"50674_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/10408690390826509","volume":"43","author":"M Lopez-Velez","year":"2003","unstructured":"Lopez-Velez, M., Martinez-Martinez, F. & Del Valle-Ribes, C. The study of phenolic compounds as natural antioxidants in wine. Crit. Rev. Food Sci. Nutr. 43, 233\u2013244, https:\/\/doi.org\/10.1080\/10408690390826509 (2003).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"50674_CR29","doi-asserted-by":"publisher","first-page":"184241","DOI":"10.1155\/2015\/184241","volume":"2015","author":"Y Abba","year":"2015","unstructured":"Abba, Y., Hassim, H., Hamzah, H. & Noordin, M. M. Antiviral Activity of Resveratrol against Human and Animal Viruses. Adv. Virol. 2015, 184241, https:\/\/doi.org\/10.1155\/2015\/184241 (2015).","journal-title":"Adv. Virol."},{"key":"50674_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3748\/wjg.v16.i2.184","volume":"16","author":"M Nakamura","year":"2010","unstructured":"Nakamura, M. et al. An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J. Gastroenterol. 16, 184\u2013192, https:\/\/doi.org\/10.3748\/wjg.v16.i2.184 (2010).","journal-title":"World J. Gastroenterol."},{"key":"50674_CR31","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s12013-014-0055-9","volume":"70","author":"K Cheng","year":"2014","unstructured":"Cheng, K., Wu, Z., Gao, B. & Xu, J. Analysis of influence of baicalin joint resveratrol retention enema on the TNF-alpha, SIgA, IL-2, IFN-gamma of rats with respiratory syncytial virus infection. Cell Biochem. Biophys. 70, 1305\u20131309, https:\/\/doi.org\/10.1007\/s12013-014-0055-9 (2014).","journal-title":"Cell Biochem. Biophys."},{"key":"50674_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.antiviral.2006.07.004","volume":"72","author":"JJ Docherty","year":"2006","unstructured":"Docherty, J. J., Sweet, T. J., Bailey, E., Faith, S. A. & Booth, T. Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res. 72, 171\u2013177, https:\/\/doi.org\/10.1016\/j.antiviral.2006.07.004 (2006).","journal-title":"Antiviral Res."},{"key":"50674_CR33","doi-asserted-by":"publisher","first-page":"e51306","DOI":"10.1371\/journal.pone.0051306","volume":"7","author":"JL Espinoza","year":"2012","unstructured":"Espinoza, J. L., Takami, A., Trung, L. Q., Kato, S. & Nakao, S. Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells. PLoS One 7, e51306, https:\/\/doi.org\/10.1371\/journal.pone.0051306 (2012).","journal-title":"PLoS One"},{"key":"50674_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.antiviral.2017.02.005","volume":"141","author":"WG Saw","year":"2017","unstructured":"Saw, W. G., Pan, A., Manimekalai, M. S. S. & Gruber, G. Structural features of Zika virus non-structural proteins 3 and-5 and its individual domains in solution as well as insights into NS3 inhibition. Antiviral Res. 141, 73\u201390, https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.005 (2017).","journal-title":"Antiviral Res."},{"key":"50674_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijantimicag.2005.09.002","volume":"26","author":"TP Cushnie","year":"2005","unstructured":"Cushnie, T. P. & Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26, 343\u2013356 (2005).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"50674_CR36","doi-asserted-by":"publisher","first-page":"e60082","DOI":"10.1371\/journal.pone.0060082","volume":"8","author":"A Aryan","year":"2013","unstructured":"Aryan, A., Anderson, M. A., Myles, K. M. & Adelman, Z. N. TALEN-based gene disruption in the dengue vector Aedes aegypti. PLoS One 8, e60082, https:\/\/doi.org\/10.1371\/journal.pone.0060082 (2013).","journal-title":"PLoS One"},{"key":"50674_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/mnfr.200500022","volume":"49","author":"C Alarcon De La Lastra","year":"2005","unstructured":"Alarcon De La Lastra, C. & Villegas, I. Resveratrol as an anti\u2010inflammatory and anti\u2010aging agent: Mechanisms and clinical implications. Mol. Nutr. Food Res. 49, 405\u2013430 (2005).","journal-title":"Mol. Nutr. Food Res."},{"key":"50674_CR38","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1042\/bst0351156","volume":"35","author":"CA de la Lastra","year":"2007","unstructured":"de la Lastra, C. A. & Villegas, I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 35, 1156\u20131160, https:\/\/doi.org\/10.1042\/bst0351156 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"50674_CR39","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1086\/429694","volume":"191","author":"AT Palamara","year":"2005","unstructured":"Palamara, A. T. et al. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 191, 1719\u20131729, https:\/\/doi.org\/10.1086\/429694 (2005).","journal-title":"J. Infect. Dis."},{"key":"50674_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1006\/phrs.2002.0992","volume":"45","author":"GJ Kapadia","year":"2002","unstructured":"Kapadia, G. J. et al. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 45, 499\u2013505, https:\/\/doi.org\/10.1006\/phrs.2002.0992 (2002).","journal-title":"Pharmacol. Res."},{"key":"50674_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0166-3542(99)00042-X","volume":"43","author":"JJ Docherty","year":"1999","unstructured":"Docherty, J. J. et al. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43, 145\u2013155 (1999).","journal-title":"Antiviral Res."},{"key":"50674_CR42","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s10753-012-9452-7","volume":"35","author":"XH Xie","year":"2012","unstructured":"Xie, X. H. et al. Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. Inflammation 35, 1392\u20131401, https:\/\/doi.org\/10.1007\/s10753-012-9452-7 (2012).","journal-title":"Inflammation"},{"key":"50674_CR43","doi-asserted-by":"publisher","first-page":"13061","DOI":"10.1128\/JVI.05869-11","volume":"85","author":"N Zang","year":"2011","unstructured":"Zang, N. et al. Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice. J. Virol. 85, 13061\u201313068, https:\/\/doi.org\/10.1128\/JVI.05869-11 (2011).","journal-title":"J. Virol."},{"key":"50674_CR44","doi-asserted-by":"publisher","first-page":"e0116879","DOI":"10.1371\/journal.pone.0116879","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs\/NF-\u03baB signaling pathway. PLoS One 10, e0116879 (2015).","journal-title":"PLoS One"},{"key":"50674_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/QAD.0000000000000168","volume":"28","author":"A Heredia","year":"2014","unstructured":"Heredia, A. et al. Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine (FTC)-resistant HIV-1. AIDS 28, 317\u2013323 (2014).","journal-title":"AIDS"},{"key":"50674_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5505\/tjps.2016.40085","volume":"13","author":"HG Anlar","year":"2016","unstructured":"Anlar, H. G., Bacanli, M., Kutluk, B., Ahmet, A. & Ba\u015faran, N. B. Cytotoxic activity of resveratrol in different cell lines evaluated by MTT and NRU assays. Turkish Journal of Pharmaceutical Sciences 13, 109\u2013118 (2016).","journal-title":"Turkish Journal of Pharmaceutical Sciences"},{"key":"50674_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1124\/dmd.104.000885","volume":"32","author":"T Walle","year":"2004","unstructured":"Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E. & Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 32, 1377\u20131382, https:\/\/doi.org\/10.1124\/dmd.104.000885 (2004).","journal-title":"Drug Metabolism and Disposition"},{"key":"50674_CR48","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1055-9965.Epi-07-0022","volume":"16","author":"DJ Boocock","year":"2007","unstructured":"Boocock, D. J. et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidem Biomar 16, 1246\u20131252, https:\/\/doi.org\/10.1158\/1055-9965.Epi-07-0022 (2007).","journal-title":"Cancer Epidem Biomar"},{"key":"50674_CR49","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1177\/0091270009339191","volume":"49","author":"T Nunes","year":"2009","unstructured":"Nunes, T. et al. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. J Clin Pharmacol 49, 1477\u20131482, https:\/\/doi.org\/10.1177\/0091270009339191 (2009).","journal-title":"J Clin Pharmacol"},{"key":"50674_CR50","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-10-2364","volume":"70","author":"VA Brown","year":"2010","unstructured":"Brown, V. A. et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70, 9003\u20139011, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2364 (2010).","journal-title":"Cancer Res"},{"key":"50674_CR51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1258\/ebm.2011.010339","volume":"236","author":"YS Lin","year":"2011","unstructured":"Lin, Y. S. et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp. Biol. Med. 236, 515\u2013523, https:\/\/doi.org\/10.1258\/ebm.2011.010339 (2011).","journal-title":"Exp. Biol. Med."},{"key":"50674_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/1096-9071(20000201)63:2<143::AID-JMV1009>3.0.CO;2-L","volume":"63","author":"CF Lin","year":"2001","unstructured":"Lin, C. F. et al. Generation of IgM anti-platelet autoantibody in dengue patients. J. Med. Virol. 63, 143\u2013149 (2001).","journal-title":"J. Med. Virol."},{"key":"50674_CR53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jmv.10261","volume":"69","author":"CF Lin","year":"2003","unstructured":"Lin, C. F. et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol. 69, 82\u201390, https:\/\/doi.org\/10.1002\/jmv.10261 (2003).","journal-title":"J. Med. Virol."},{"key":"50674_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.antiviral.2004.03.002","volume":"63","author":"DL Evers","year":"2004","unstructured":"Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y. & Huang, E. S. 3,4\u2032,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Res. 63, 85\u201395, https:\/\/doi.org\/10.1016\/j.antiviral.2004.03.002 (2004).","journal-title":"Antiviral Res."},{"key":"50674_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/09637480903430990","volume":"61","author":"AA Matias","year":"2010","unstructured":"Matias, A. A. et al. Portuguese winemaking residues as a potential source of natural anti-adenoviral agents. Int. J. Food Sci. Nutr. 61, 357\u2013368, https:\/\/doi.org\/10.3109\/09637480903430990 (2010).","journal-title":"Int. J. Food Sci. Nutr."},{"key":"50674_CR56","doi-asserted-by":"publisher","unstructured":"Chan, C. N., Trinite, B. & Levy, D. N. Potent inhibition of HIV-1 replication in resting CD4 T cells by resveratrol and pterostilbene. Antimicrob. Agents Chemother. 61, https:\/\/doi.org\/10.1128\/AAC.00408-17 (2017).","DOI":"10.1128\/AAC.00408-17"},{"key":"50674_CR57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jmv.24660","volume":"89","author":"YS Han","year":"2017","unstructured":"Han, Y. S. et al. Identification of Resveratrol Analogs as Potent Anti-Dengue Agents Using a Cell-Based Assay. J. Med. Virol. 89, 397\u2013407, https:\/\/doi.org\/10.1002\/jmv.24660 (2017).","journal-title":"J. Med. Virol."},{"key":"50674_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/srep05452","volume":"4","author":"E Moghaddam","year":"2014","unstructured":"Moghaddam, E. et al. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 4, 5452, https:\/\/doi.org\/10.1038\/srep05452 (2014).","journal-title":"Sci. Rep."},{"key":"50674_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1471-2148-13-213","volume":"13","author":"BT Teoh","year":"2013","unstructured":"Teoh, B. T. et al. Dengue virus type 1 clade replacement in recurring homotypic outbreaks. BMC Evol. Biol. 13, 213, https:\/\/doi.org\/10.1186\/1471-2148-13-213 (2013).","journal-title":"BMC Evol. Biol."},{"key":"50674_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep22332","volume":"6","author":"MH Shu","year":"2016","unstructured":"Shu, M. H. et al. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii. Sci. Rep. 6, 22332, https:\/\/doi.org\/10.1038\/srep22332 (2016).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50674-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50674-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:23:28Z","timestamp":1671269008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50674-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50674-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14336"}}